Pancreatic Cancer Research

ResearcherMedical College of WisconsinActive in the last 2 years

Sam Z. Thalji

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-2681-2109; OpenAlex author ID A5029104507, A5046498204, A5056932806. Sources: OpenAlex.

Their work

Papers
7
Trials
0
Grants
0
Labs led
0
Collaborators
27
Papers, trials and grants by year

2023: 3 papers · 2024: none · 2025: none · 2026: 4 papers

Papers 7

  1. AI-Derived Electronic Tumor Marker For Cancer Antigen 19-9 Nonproducers With Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1001/jamasurg.2026.0291↗
  2. Perioperative Chemotherapy and Total Neoadjuvant Chemotherapy for Pancreatic Adenocarcinoma. Co-author DOI 10.1016/j.soc.2025.05.003↗
  3. MEK inhibitor-based genomically matched combinatorial targeted therapies in metastatic pancreatic adenocarcinoma with KRAS alterations. Co-author DOI 10.1093/oncolo/oyag040↗
  4. Mutant and Wild-Type RAS Cross-talk and Stoichiometric Deficiencies Are Determinants of Sensitivity to Targeted Therapies in KRASG12R Pancreatic Ductal Adenoca… Co-author DOI 10.1158/0008-5472.can-25-0018↗
  5. Neoadjuvant chemotherapy for pancreatic cancer: Quality over quantity. Co-author DOI 10.1002/jso.27265↗
  6. Biliary Adverse Events During Neoadjuvant Therapy for Pancreatic Cancer. Co-author DOI 10.1097/sla.0000000000005884↗
  7. CA19-9 Response to First-Line Neoadjuvant FOLFIRINOX and Second-Line Gemcitabine/Nab-Paclitaxel for Patients with Operable Pancreatic Cancer. Co-author DOI 10.1245/s10434-022-13055-1↗

Closest collaborators

The 25 strongest of 27 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Callisia Nathelee Clarke · 5 shared papers, 2023–2026 · strength 1.34
  2. Mohammed Aldakkak · 6 shared papers, 2023–2026 · strength 1.18
  3. Mandana Kamgar · 6 shared papers, 2023–2026 · strength 1.18
  4. William Adrian Hall · 5 shared papers, 2023–2026 · strength 0.91
  5. Kathleen K. Christians · 5 shared papers, 2023–2026 · strength 0.91
  6. Douglas B. Evans · 4 shared papers, 2023–2026 · strength 0.69
  7. Susan Tsai · 4 shared papers, 2023–2026 · strength 0.69
  8. Bradley A. Erickson · 3 shared papers, 2023 · strength 0.48
  9. Ben George · 3 shared papers, 2023 · strength 0.48
  10. Thomas B. McFall · 2 shared papers, 2026 · strength 0.48
  11. Razelle Kurzrock · 2 shared papers, 2026 · strength 0.48
  12. Nikki K. Lytle · 2 shared papers, 2026 · strength 0.43
  13. Beth E. Erickson · 2 shared papers, 2026 · strength 0.43
  14. Elizabeth Diane Auckley · 1 shared paper, 2026 · strength 0.27
  15. Anai N. Kothari · 1 shared paper, 2026 · strength 0.22
  16. Douglas B. Evans · 1 shared paper, 2026 · strength 0.22
  17. Ben George · 1 shared paper, 2026 · strength 0.22
  18. Yongwoo David Seo · 1 shared paper, 2026 · strength 0.21
  19. Rachel A. Burge · 1 shared paper, 2026 · strength 0.21
  20. Ben George · 1 shared paper, 2026 · strength 0.21
  21. Daniel Dorbin · 1 shared paper, 2026 · strength 0.21
  22. Channing J. Der · 1 shared paper, 2026 · strength 0.21
  23. G. Aaron Hobbs · 1 shared paper, 2026 · strength 0.21
  24. Parag P. Tolat · 1 shared paper, 2023 · strength 0.17
  25. Naveen M. Kulkarni · 1 shared paper, 2023 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.